Legal News

Mylan Investigated for Antitrust Violations
Download PDF
1 Star2 Stars3 Stars4 Stars5 Stars (No Ratings Yet)


Summary: After increasing the price of EpiPens so that they are no longer affordable, drugmaker Mylan is being investigated for antitrust violations.

Mylan Pharmaceuticals is being investigated by New York state’s top legal office for the possibility that the drugmaker has broken antitrust laws over the pricing of its EpiPen. New York Attorney General Eric Schneiderman announced that a preliminary analysis had begun into Mylan by his office, including items such as the terms of sales in contracts with local schools.


Schneiderman said, “No child’s life should be put at risk because a parent, school or health care provider cannot afford a simple, life-saving device because of a drugmaker’s anti-competitive practices. Allergy sufferers have enough concerns to worry about – the availability of life-saving medical treatment should not be one of them.”

Read EpiPen CEO Tied to Democratic Senator.

EpiPen’s are the most popular method of epinephrine autoinjector on the market. The drug is used to treat those having a severe allergic reaction. Mylan increased the price of the EpiPen over 400 percent since 2009. This has raised concern by consumer advocates and critics.

Get JD Journal in Your Mail

Subscribe to our FREE daily news alerts and get the latest updates on the most happening events in the legal, business, and celebrity world. You also get your daily dose of humor and entertainment!!

A generic version was supposed to be made but the FDA has not approved one yet, leaving Mylan’s EpiPen as the only option for consumers that have to pay the price if they want to protect themselves and loved ones. Mylan has stated they will offer a generic version for $300 for the two-pack instead of the $600. They also state they will offer more discounts to make it affordable to users. The EpiPen brings in around $1 billion in profit a year for the pharmaceutical company.

See Big Pharma, Biotech Companies Ask for Patent Protections.

Mylan has given over 700,000 EpiPens for free to more than 65,000 schools across the country. They have also dropped the purchase requirement for schools looking to buy EpiPens at a discount.

Do you think Mylan has done anything wrong by dramatically increasing the price of the life-saving drug? Tell us in the comments below.

To learn more about Mylan, read Retaliation Lawsuit Brought Against Mylan Pharmaceuticals by Ex-Employee.



Interesting Legal Sites You May Like




Search Now

Personal Injury Attorney with 3+ Years of Experience

USA-CA-Sherman Oaks

Sherman Oaks office of our client is seeking a personal injury attorney with 3+ years of CA experien...

Apply Now

Senior Trust and Estate Attorney/ Of Counsel

USA-CA-San Diego

San Diego office is seeking a trust and estate attorney at either the senior associate or of counsel...

Apply Now

Mid-level Litigation Securities Associate Attorney

USA-NY-New York City

New York City office of an AmLaw firm seeks Mid-level Litigation Securities Associate Attorney with ...

Apply Now


Litigation Attorneys

USA-CA-Pleasant Hill

Civil litigation defense firm with offices in Contra Costa and Solano Counties, seeking litigation a...

Apply now

Senior Litigation Associate Attorney

USA-CA-Los Angeles

Gaglione, Dolan & Kaplan is looking to hire an associate attorney with 5 + years experience in insur...

Apply now

Associate Attorney


Manning Gross + Massenburg LLP (MG+M) is currently recruiting a junior to mid-level Associate for ou...

Apply now

Director of Resolution

USA-CA-Los Angeles

Tax firm seeks heavily seasoned attorney for director of resolution role. Min. 5 yrs of tax experien...

Apply now

Most Popular


To Top